Press Release ImevaX secures EUR 7.5 million in Series A Financing to develop highly specific vaccine against Helicobacter pylori infections Munich (Germany), October 28, 2014: ImevaX GmbH, a specialist in vaccines agai

First Page		Document Content
Date: 2014-10-28 05:44:28		Press Release ImevaX secures EUR 7.5 million in Series A Financing to develop highly specific vaccine against Helicobacter pylori infections Munich (Germany), October 28, 2014: ImevaX GmbH, a specialist in vaccines agai Add to Reading List Source URL: www.biomedvc.com Download Document from Source Website File Size: 106,79 KB Share Document on Facebook